These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32104426)

  • 1. Enhanced transdermal delivery of meloxicam by nanocrystals: Preparation,
    Yu Q; Wu X; Zhu Q; Wu W; Chen Z; Li Y; Lu Y
    Asian J Pharm Sci; 2018 Nov; 13(6):518-526. PubMed ID: 32104426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Evaluation of Meloxicam Nanocrystals by Oral Administration with Different Particle Sizes.
    Yu Y; Tian Y; Zhang H; Jia Q; Chen X; Kang D; Du Y; Song S; Zheng A
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam.
    Jiang Q; Wang J; Ma P; Liu C; Sun M; Sun Y; He Z
    Drug Deliv Transl Res; 2018 Feb; 8(1):64-72. PubMed ID: 29181834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Mar; 92(6-7):383-92. PubMed ID: 23353874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocrystallization as a novel approach to enhance the transdermal administration of meloxicam.
    Machado TC; Gelain AB; Rosa J; Cardoso SG; Caon T
    Eur J Pharm Sci; 2018 Oct; 123():184-190. PubMed ID: 30031860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
    Shaji J; Menon I
    Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smartcrystals for Efficient Dissolution of Poorly Water-Soluble Meloxicam.
    Ambrus R; Alshweiat A; Szabó-Révész P; Bartos C; Csóka I
    Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35213978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of spray drying technique for improvement of dissolution and anti-inflammatory effect of Meloxicam.
    Shazly G; Badran M; Zoheir K; Alomrani A
    Pak J Pharm Sci; 2015 Jan; 28(1):103-11. PubMed ID: 25553688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and
    Khan MI; Yaqoob S; Madni A; Akhtar MF; Sohail MF; Saleem A; Tahir N; Khan KU; Qureshi OS
    Biomed Res Int; 2022; 2022():8170318. PubMed ID: 36483631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide.
    Fathanah A; Setyawan D; Sari R
    J Basic Clin Physiol Pharmacol; 2019 Dec; 30(6):. PubMed ID: 31837256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eudragit EPO nanoparticles: application in improving therapeutic efficacy and reducing ulcerogenicity of meloxicam on oral administration.
    Khachane P; Date AA; Nagarsenker MS
    J Biomed Nanotechnol; 2011 Aug; 7(4):590-7. PubMed ID: 21870464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan Nanoparticles for Meloxicam Ocular Delivery: Development, In Vitro Characterization, and In Vivo Evaluation in a Rabbit Eye Model.
    Mohamed HB; Attia Shafie MA; Mekkawy AI
    Pharmaceutics; 2022 Apr; 14(5):. PubMed ID: 35631479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Administration System Based on Meloxicam Nanocrystals: Decreased Dose Due to High Bioavailability Attenuates Risk of Gastrointestinal Side Effects.
    Nagai N; Ogata F; Otake H; Kawasaki N
    Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32244754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin.
    Bandarkar FS; Vavia PR
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1318-28. PubMed ID: 21506882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S; Reddy VA; Arora S; Patel K
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of meloxicam eutectics with mandelic acid and saccharin for enhanced solubility.
    Fernandes RP; de Carvalho ACS; Ekawa B; do Nascimento ALSC; Pironi AM; Chorilli M; Caires FJ
    Drug Dev Ind Pharm; 2020 Jul; 46(7):1092-1099. PubMed ID: 32475190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flexosomes for transdermal delivery of meloxicam: characterization and antiinflammatory activity.
    Alomrani AH; Badran MM
    Artif Cells Nanomed Biotechnol; 2017 Mar; 45(2):305-312. PubMed ID: 26924417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan Encapsulated Meloxicam Nanoparticles for Sustained Drug Delivery Applications: Preparation, Characterization, and Pharmacokinetics in Wistar Rats.
    Yegireddy M; Nadoor P; Rao S; Hanumanthu PB; Rajashekaraiah R; Ramachandrappa SC; Halemani GM; Mannem S; Prasad TNVKV; Ubaradka S
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions.
    Dehghani H; Taheri A; Homayouni A
    Curr Drug Deliv; 2017; 14(5):709-717. PubMed ID: 27142108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.